Cialis sales in Europe on the steep rise.

Published: 2003-05-21 06:57:00

Updated: 2003-05-21 06:57:00

Elli Lilly launched Cialis, a new anti-impotence drug, to the European market in Feb. this year with so favorable response that the already preoccupied markets with Viagra seemed to be gradually tuned over to Cialis.

Dr. Edorado S. Pescadtori, who took part in the conference of the European ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK